Study identifies biomarker for the onset & progression of MS

A board to discuss Low Dose Naltrexone (LDN) as a treatment for Multiple Sclerosis

Study identifies biomarker for the onset & progression of MS

Postby MSUK » Wed Sep 27, 2017 3:04 am

A team of researchers have identified Opioid Growth Factor (OGF) as a novel biomarker for the onset and progression of multiple sclerosis (MS)...Read more - http://www.ms-uk.org/study-identifies-biomarker-onset-and-progression-ms

Image
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2876
Joined: Wed Oct 14, 2009 2:00 pm

Advertisement

Return to Low Dose Naltrexone

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service